Literature DB >> 28070740

Generating Evidence of Clinical Outcomes of Drug-Drug Interactions.

Katsiaryna Bykov1,2, Joshua J Gagne3,4.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28070740     DOI: 10.1007/s40264-016-0496-8

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  28 in total

1.  Concordance of severity ratings provided in four drug interaction compendia.

Authors:  Jacob Abarca; Daniel C Malone; Edward P Armstrong; Amy J Grizzle; Philip D Hansten; Robin C Van Bergen; Richard B Lipton
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Mar-Apr

Review 2.  Pharmacoepidemiologic Methods for Studying the Health Effects of Drug-Drug Interactions.

Authors:  S Hennessy; C E Leonard; J J Gagne; J H Flory; X Han; C M Brensinger; W B Bilker
Journal:  Clin Pharmacol Ther       Date:  2015-11-23       Impact factor: 6.875

3.  Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study.

Authors:  Hadas D Fischer; David N Juurlink; Muhammad M Mamdani; Alexander Kopp; Andreas Laupacis
Journal:  Arch Intern Med       Date:  2010-04-12

4.  Investigating the Additive Interaction of QT-Prolonging Drugs in Older People Using Claims Data.

Authors:  Andreas D Meid; Anna von Medem; Dirk Heider; Jürgen-Bernhard Adler; Christian Günster; Hanna M Seidling; Renate Quinzler; Hans-Helmut König; Walter E Haefeli
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606

5.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

6.  Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.

Authors:  Richard T Scheife; Lisa E Hines; Richard D Boyce; Sophie P Chung; Jeremiah D Momper; Christine D Sommer; Darrell R Abernethy; John R Horn; Stephen J Sklar; Samantha K Wong; Gretchen Jones; Mary L Brown; Amy J Grizzle; Susan Comes; Tricia Lee Wilkins; Clarissa Borst; Michael A Wittie; Daniel C Malone
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

7.  Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors.

Authors:  Katsiaryna Bykov; Sebastian Schneeweiss; Macarius M Donneyong; Yaa-Hui Dong; Niteesh K Choudhry; Joshua J Gagne
Journal:  Am J Cardiol       Date:  2016-11-16       Impact factor: 2.778

8.  Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding.

Authors:  H Schelleman; W B Bilker; C M Brensinger; X Han; S E Kimmel; S Hennessy
Journal:  Clin Pharmacol Ther       Date:  2008-08-06       Impact factor: 6.875

9.  Recommendations for selecting drug-drug interactions for clinical decision support.

Authors:  Hugh Tilson; Lisa E Hines; Gerald McEvoy; David M Weinstein; Philip D Hansten; Karl Matuszewski; Marianne le Comte; Stefanie Higby-Baker; Joseph T Hanlon; Lynn Pezzullo; Kathleen Vieson; Amy L Helwig; Shiew-Mei Huang; Anthony Perre; David W Bates; John Poikonen; Michael A Wittie; Amy J Grizzle; Mary Brown; Daniel C Malone
Journal:  Am J Health Syst Pharm       Date:  2016-04-15       Impact factor: 2.637

10.  Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study.

Authors:  Heleen van der Sijs; Ravi Kowlesar; A Peter J Klootwijk; Stefan P Nelwan; Arnold G Vulto; Teun van Gelder
Journal:  Br J Clin Pharmacol       Date:  2008-12-10       Impact factor: 4.335

View more
  2 in total

1.  Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis.

Authors:  Katsiaryna Bykov; Sebastian Schneeweiss; Robert J Glynn; Murray A Mittleman; David W Bates; Joshua J Gagne
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

2.  Drug-drug Interaction-related Uncontrolled Glycemia.

Authors:  Mohamed Anwar Hammad; Balamurugan Tangiisuran; Abeer Mohamed Kharshid; Noorizan Abdul-Aziz; Yahaya Hassan; Nor Azizah Aziz; Tarek Mohamed Elsayed
Journal:  J Pharm Bioallied Sci       Date:  2017 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.